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Sphingolipids play an important role in the homeostasis
and barrier function of human stratum corneum. A dis-
turbance of sphingolipid formation is supposed to be a
crucial factor for the increased transepidermal water
loss in common skin diseases like atopic eczema or
psoriasis. The key enzyme for de novo sphingolipid
synthesis is serine palmitoyltransferase, which consists
of two di¡erent subunits, named LCB1 and LCB2 pro-
teins. In order to investigate the induction of LCB2
synthesis in human epidermis, skin barrier disruption
was performed by tape stripping on the forearm of
healthy volunteers enough to obtain a 3^4-fold increase
in transepidermal water loss. Skin punch biopsies were
taken before and 0.5, 2, 4, and 8 h after tape stripping by
each volunteer to measure LCB2 at the mRNA level.
Additional biopsies taken before and 12 h after tape
stripping were used to evaluate LCB2 at the protein
level. Our results show that 0.5 and 2 h after tape strip-
ping the LCB2 mRNA expression was decreased com-
pared to control in all cases. A signi¢cant increase in
LCB2 mRNA expression was detectable 4 h after bar-
rier disruption, with individual variations; no further
increase was detectable 8 h after tape stripping. Immu-
nohistochemical analysis 12 h after barrier disruption
showed increased LCB2 immunolocalization in the in-
ner epidermis, whereas in the outer epidermis it was
similar to control. LCB2 mRNA expression preceded
the expression of the corresponding protein by 4^8 h.
Our ¢ndings support the concept that an increase in
transepidermal water loss is an obligatory trigger for
the upregulation of serine palmitoyltransferase mRNA
expression in humans. Key words: epidermal lipids/serine
palmitoyltransferase/skin barrier disruption/TEWL. J Invest
Dermatol 119:1048^1052, 2002
T
he stratum corneum provides protection of the un-
derlying skin against environmental noxious in£u-
ences. At the same time it builds a barrier against
transepidermal water loss (TEWL) from the underly-
ing structures to the outside and has been character-
ized as a dynamic and metabolically interactive tissue. Its architec-
ture has been described best by the ‘‘bricks and mortar’’ model
(Elias, 1983) in which epidermal lipids represent the most impor-
tant component in the formation of the cutaneous permeability
barrier. Mainly composed of cholesterol, ceramides, and free fatty
acids, they form a multilamellar bilayer structure, which regulates
barrier function (Elias, 1981; Lampe et al, 1983; Abraham et al, 1987;
Downing et al, 1987; Grubauer et al, 1989a; Holleran et al, 1995).
Ceramides in particular have been shown to have a distinctive
role in epidermal permeability barrier homeostasis (Holleran
et al, 1991b).
The enzymes involved in the synthesis of stratum corneum
lipids have been well characterized. Serine palmitoyltransferase
(SPT) is the key enzyme for de novo sphingolipid synthesis
(Holleran et al, 1991a). Additionally, there are two pathways for
ceramide generation from glucosyl ceramides and from sphingo-
myelin, catalyzed by b-glucocerebrosidase and by sphingomyeli-
nase, respectively (Holleran et al, 1994; Jensen et al, 1999). One
important signal for the upregulation of skin lipid enzymes is
barrier disruption manifested by an increase inTEWL (Grubauer
et al, 1987; 1989b). The mRNA levels of the most important
enzymes like HMG-CoA reductase, HMG-CoA synthase, farne-
syl pyrophosphate, and squalene synthase for cholesterol synth-
esis, acetyl-CoA carboxylase and fatty acid synthase for fatty acid
synthesis, as well as SPT for de novo sphingolipid synthesis in-
crease after acute barrier disruption as has been shown in hairless
mice (Harris et al, 1997). Other studies in hairless mice have de-
monstrated a delayed increase in epidermal sphingolipid synthesis
in response to skin barrier abrogation, which contrasts with the
immediate response of cholesterol and fatty acid synthesis and
con¢rmed the role of sphingolipids for the maintenance of the
epidermal permeability barrier (Holleran et al, 1991a; 1991b). No
data have been published on the regulation of gene expression of
these enzymes in human skin. Mammalian SPT comprises a
complex of two subunits named LCB1 and LCB2, with 30%
amino acid identity. LCB2 genes have been shown to encode
SPT (Weiss and Sto¡el, 1997). To evaluate the e¡ect of skin bar-
rier disruption followed by an increase in TEWL on LCB2
mRNA and protein expression in human epidermis we quanti-
¢ed the LCB2 reverse transcriptase polymerase chain reaction
(RT-PCR) products and we localized LCB2 protein before and
at di¡erent time points after barrier disruption.
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MATERIALS AND METHODS
Source of tissue The skin of the solar side of the forearm of six healthy
(no skin disease and no personal history of atopy) young men (mean
age 3273 y), who had been told neither to apply topical preparations
nor to wash the site of investigation 24 h prior to examination, was tape-
stripped using cellophane tape (tesa-¢lm, Beiersdorf, Hamburg, Germany).
Tape stripping was performed in four areas of approximately 4 cm2 each,
enough to increase theTEWL by three to four times. TEWLwas measured
at 201C in a climatized closed room with a relative humidity of 40%
using an Evaporimeter (EP1, Servo Medical, Stockholm, Sweden). Three
millimeter punch biopsies were taken from each area 0.5, 2, 4, and 8 h
after tape stripping. An additional 3 mm punch biopsy was taken without
tape stripping and served as control. Immediately after removal, the tissue
biopsies were transported in Dulbecco’s modi¢ed Eagle’s medium for
further processing.
Preparation of the epidermis The biopsies were washed in phosphate-
bu¡ered saline (PBS) and digested in 0.5% dispase solution (Roche
Diagnostics, Mannheim, Germany) for 2 h at 371C. Then the epidermis
was mechanically separated, frozen in liquid nitrogen, and stored at
701C.
Isolation of mRNA The epidermis was harvested in solution bu¡er
(QuickPreps mRNA bu¡er, Pharmacia, Uppsala, Sweden) and sonicated
for 10 s to destroy the cell membranes without degrading the nucleic acids.
Further isolation was performed in three steps following the supplier’s
protocol (Pharmacia). After ethanol precipitation the harvested mRNA
was diluted in 50 ml H2O aliquots.
Deoxyribonuclease (DNAse) digestion To avoid DNA contamin-
ation the mRNA was digested with 10 U DNAse (Roche Diagnostics)
with the addition of 10 U RNAse inhibitor (Roche Diagnostics)
followed by phenol/chloroform extraction and ethanol precipitation.
RT-PCR For reverse transcription mRNA probes were diluted in 11 ml
H2O and heated together with 0.5 mg oligo(dt)12^18 primer at 701C
for 10 min. The reverse transcription reaction was performed at 421C
in 20 mM Tris-HCl, pH 8.4, 50 mM KCl, 2.5 mM MgCl2, 0.01 M
dithiothreitol, 1 mM dNTP mix, and 200 U SUPERSCRIPT II reverse
transcriptase (Gibco BRL, Eggenstein, Germany) for 60 min and stopped
at 701C for 15 min. To nick the mRNA strand, the sample was incubated
with 2 U RNAse H (Gibco BRL) for 20 min at 371C.
For each experiment, primer concentrations, RNA amounts, and PCR
cycles were titrated to establish standard conditions. The validity of quanti-
tative comparisons of PCR products was insured by using a number of
PCR cycles mapped to within the linear curve. For PCR 1^3 ml of the
sample was incubated in 20 mM Tris-HCl, pH 8.4, 50 mM KCl, 1.5 mM
MgCl2, 200 mM dNTP mix, and 0.2 pmol of the chosen primer. The
thermal pro¢le used on a Hybaid Limited TouchDownt Thermal Cycler
(Hybaid, Middlesex, U.K.) consisted of denaturation at 941C for 45 s,
annealing at 531C for 30 s, and an extension temperature of 721C for
1 min for 32 cycles. With optimized conditions, the PCR runs were
repeated on the same RNA samples to assure the reproducibility of the
data. Previous studies showed that there is a paucity of low density
lipoprotein receptors expressed in human epidermis (Ponec et al, 1983;
Williams et al, 1987). In order to exclude the presence of nonspeci¢c
mRNA in the epidermis, RT-PCR for low density lipoprotein receptor
(LDLR) was performed on the same tissue biopsies before barrier
disruption and using the same conditions as for LCB2.
Oligonucleotides used for PCRwere as follows: LCB2 (forward primer
50 -GCTATTGAAAGATGCCATTG-30, reverse primer 50 -GATCTGCTC-
CACTACAGG-30) (GenBank accession no. U15555), low density lipoprotein
receptor primer (forward primer 50 -CAATGTCTCACCAAGCTCTG-30,
reverse primer 50 -TCTGTCTCGAGGGGTAGCTG-30) (GenBank accession
no. NM000527), as an external negative control, and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) primer as an internal standard (for-
ward primer 50 -GGTGAAGGTCGGAGTCAACGGA-30, reverse primer
50 -GAGGGATCTCGCTCCTGGAAGA-30) (GenBank accession no. M33197).
Quanti¢cation of RT-PCR products and statistics PCR reactions
were separated by gel electrophoresis on 2% agarose gels stained with
0.4 mg per ml ethidium bromide. The gels were visualized over an on-line
ultraviolet light source transilluminator (Gel Doc 1000 Video docu-
mentation System, Bio-Rad, Hercules, CA). The PCR products of the
expected size (387 bp for SPT, 238 bp for LDLR, and 430 bp for
GAPDH) were then manually de¢ned and the band intensity was
quanti¢ed using Quantity One quantitation software (Bio-Rad). The
intensities of the PCR bands of LCB2 were expressed normalized to
GAPDH. For statistical analysis a t test was performed. A p-value below
0.05 was considered to be signi¢cant.
Immunohistochemistry For the immunohistochemical study, repre-
sentative tissue biopsies taken at 12 h after tape stripping and the
corresponding controls taken before tape stripping were snap frozen in
liquid nitrogen for cryostat sectioning. Frozen tissue samples were
submerged in Optimum Cutting Temperature embedding compound
(OCT, Tissue-Tek, Miles Laboratory, Elkhart, IN) and cryostat sections
(4 mm) were prepared on positively charged polylysine-coated slides and
allowed to air-dry. Tissue ¢xation was obtained with fresh 2%
paraformaldehyde (Sigma, Deisenhofen, Germany) in PBS for 5 min and
methanol for 10 min at 41C.
All tissue sections were further processed for indirect immuno-histo-
chemistry with an ABC-based method (Vector Laboratories, Burlingame,
CA). After blocking both endogenous biotin binding sites with sequential
incubations of avidin and biotin, and endogenous peroxidases with 15 min
incubation in methanol/1% H2O2, the sections were subjected to over-
night incubation at 41C with primary speci¢c rabbit antimouse LCB2
antibody, or control solutions. Mouse anti-LCB2 antibody was generously
donated by Professor Wilhelm Sto¡el, University of Koeln, Germany
(Weiss and Sto¡el, 1997).
The antiserum was diluted 1:200. As a positive control, a monoclonal
anticytokeratin PAN antibody (Roche Diagnostics) was used at a concen-
tration of 10 mg per ml. Negative controls included use of bu¡er alone or
dilutions of nonspeci¢c puri¢ed rabbit IgG in the primary layer (Vector
Laboratories). Antibodies were diluted in 0.1% bovine serum albumin
(BSA, Sigma) and 0.1% sodium azide (Roth, Karlsruhe, Germany) in
PBS (pH 7.4).
Speci¢c binding was detected using a biotin-conjugated horse antirabbit
and antimouse IgG, avidin^biotin peroxidase complex (Vector Labo-
ratories), and a substrate solution of H2O2 (0.03%) and diaminobenzidine
(Sigma, 2 mg per ml) in 0.5 M Tris-saline, pH 7.6, with 1 M imidazole
(Roth) and 0.3% sodium azide (Roth). The slides were then counter-
stained with hematoxylin, dehydrated through graded ethanols and xylene,
mounted, and coverslipped.
RESULTS
The mRNA expression of LCB2 is increased 4 h after tape
stripping The separation of LCB2 and GAPDH RT-PCR
products by gel electrophoresis and ethidium bromide staining
showed an increase in the mRNA expression of LCB2 4 h after
barrier disruption (Fig 1). The values of LCB2 mRNA
expression 0.5 and 2 h after tape stripping were lower compared
to control levels in all cases. Eight hours after barrier disrup-
tion no further increase in LCB2 mRNA was detected.
Interindividual di¡erences in LCB2 mRNA baseline expression
were observed. No detectable PCR band was found for low
density lipoprotein in control human skin, which con¢rmed the
speci¢city of the tissue (data not shown).
The semiquantitative assessment of the LCB2 RT-PCR bands
obtained 4 h after tape stripping and the respective controls are
represented normalized to GAPDH expression (Fig 2).We show
strong interindividual variations in LCB2 mRNA expression,
and in two individuals out of six the expression was particularly
high. In all volunteers there was a signi¢cant elevation of the
median value 4 h after tape stripping (Fig 3, p¼ 0.005).
The protein level of LCB2 is increased 12 h after tape
stripping All samples investigated showed a very similar
pattern of immunoreactivity. In control skin LCB2 protein was
localized as spotty reactions throughout all epidermal layers,
although most abundantly in the granular-corneocyte transition
zone and in the stratum basale (arrows) (Fig 4a). Also dermal
¢broblasts and in£ammatory cells stained with the antibody.
Twelve hours after tape stripping LCB2 immunolocalization
was increased in the inner epidermis compared to controls. In
the granular-corneocyte transition zone the protein level of
LCB2 was similar to control level (Fig 4b). The negative control
showed no stain (Fig 4c).
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DISCUSSION
The results of our study show that the LCB2 mRNA level is in-
creased 4 h and the protein level 12 h after acute skin barrier per-
turbation by tape stripping in humans. The mRNA expression
preceded the expression of the protein by 4^8 h. Acute barrier
disruption in mammalian skin leads to exocytosis of lamellar
bodies at the border between the outer granular layer of the epi-
dermis and the stratum corneum (Menon et al, 1992).The lamellar
bodies contain the precursor of stratum corneum lipids like gly-
cosphingolipids, phospholipids, and lipid modi¢ing enzymes
(Menon et al, 1992). There is evidence that, after accumulated
lamellar bodies are used up, fatty acid synthesis starts, which mostly
takes place in the basal layers of the epidermis (Monger et al,
1988). Interestingly, we showed by immunostaining increased
LCB2 synthesis in the basal epidermal layer. A preliminary study
where we evaluated LCB2 immunoreactivity 6 h after tape strip-
ping showed a decrease in LCB2 in the stratum basale, which is
then probably replaced by newly synthesized LCB2 12 h after
tape stripping. SPT is one of the most important lipid synthesis
enzymes involved in skin barrier homeostasis as well as in skin
barrier repair and its activity has been localized in both inner
and outer epidermis in response to acute and chronic barrier per-
turbation (Holleran et al, 1995). It catalyzes the condensation of
serine and palmitoyl-CoA yielding 3-ketosphinganine. The pro-
duct can be used directly in ceramide synthesis and is consecu-
tively modi¢ed to sphingomyelin or glycosylated to gain
glycosphingolipids (Kishimoto, 1983). SPT is a highly conserved
protein. The identity of the human and mouse fraction of the
protein used to produce the antibody anti-LCB2 obtained for
our study was 96% (Weiss and Sto¡el, 1997).We could then be
certain of cross-reactivity on human tissue (Sto¡el, personal com-
munication). The two main subunits shown to form SPTwith a
stoichiometry of 1:1, namely LCB1 and LCB2, have been puri¢ed
recently by a⁄nity peptide chromatography (Hanada et al, 2000).
Despite existing discrepancies on the role of the two subunits in
determining the enzyme activity, in our study we chose to eval-
uate the variation in the expression of the LCB2 subunit. Studies
on embryonic kidney 293 cells showed that the overexpression of
murine LCB2 cDNA was necessary and su⁄cient to enhance
SPT activity in the cells, even without the coexpression of mur-
ine LCB1 cDNA (Weiss and Sto¡el, 1997).
Direct activating factors for ceramide synthesis are not known
but ionic signals or cytokine induction are discussed (Elias, 1996).
Previous studies on rodents have shown an increase in SPT
mRNA (LCB2 subunit) 4 h after tape stripping (Harris et al,
1997) and an increase in SPT activity 5^7 h after barrier disrup-
tion, returning to normal after 12 h (Holleran et al, 1991a). In our
results we showed a similar time curve of LCB2 mRNA expres-
sion after barrier disruption, increasing 4 h after tape stripping
and returning to basal values after 8 h. The fact that the elevation
of the mRNA is not measurable 8 h after the perturbation is
remarkable because restoration of 80% of barrier function re-
quires 72^96 h and complete barrier recovery can take up to 14 d
(Tagami and Yoshikuni, 1985; Tanaka et al, 1997). On the other
Figure1. Gel electrophoresis of LCB2 RT-PCR products. Gel elec-
trophoresis of LCB2 (upper lanes) and GAPDH (lower lanes) in the epidermis
of six healthy volunteers (P1^P6) before tape stripping (0 h) and at four
di¡erent times after tape stripping (0.5, 2, 4, and 8 h). Total cellular RNA
was isolated from epidermal specimens. RT-PCR was performed with
LCB2 and GAPDH primer, stained with ethidium bromide, and separated
on a 2% agarose gel by gel electrophoresis (see Materials and Methods)
Figure 2. Semiquantitative analysis of LCB2 PCR bands. Relative
density levels of LCB2 PCR bands are expressed in percentage of
GAPDH. Control levels (left) and levels 4 h after tape stripping (right) are
shown for all volunteers (P1^P6). The densitometric values are obtained
from the corresponding ethidium-bromide-stained PCR products pre-
sented in Fig 1. There is a signi¢cant increase in mRNA expression 4 h
after barrier disruption in each volunteer.
Figure 3. Box plot of the semiquantitative analysis of LCB2 PCR
bands. Relative density levels of LCB2 PCR bands are expressed in per-
centage of GAPDH for each densitometric value obtained from the ethi-
dium-bromide-stained PCR product shown in Fig 1 at di¡erent times (0,
before tape stripping; 0.5^8 h after tape stripping). np¼ 0.005.
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hand the basal activity of all lipid modifying enzymes involved
in barrier permeability is unusually high (Proksch et al, 1990;
Holleran et al, 1991a; Ottey et al, 1995), and small di¡erences of
gene expression cannot be captured with the method of semi-
quantitative RT-PCR.
The increase of SPT after barrier disruption can be inhibited
by occlusion of the epidermis, mimicking a reduction in TEWL
(Holleran et al, 1991b). In two of our volunteers we found a rela-
tively high expression of LCB2. Those volunteers had been
examined during the summer, whereas the other biopsies had
been taken in autumn and winter. This increased expression cor-
responds to the ¢nding that total lipid amounts of stratum cor-
neum at air-exposed sites are higher in summertime than in
winter (Yoshikawa et al, 1994). The higher expression in summer-
time can be caused either by exposure to ultraviolet irradiation
(Wefers et al, 1991; Holleran et al, 1997; Farrell et al, 1998) and/or
by the occlusive e¡ect of warm winter clothing. Immunohisto-
chemical analysis revealed a very similar pattern of LCB2 immu-
noreactivity in di¡erent individuals, although the mRNA level
showed interindividual variations. This suggests that the excessive
mRNA detected in the two aforementioned cases may give simi-
lar protein levels to the other cases.
Previous studies had shown that inhibition of SPT results in
delay of barrier repair (Holleran et al, 1991b). But SPT is not the
only enzyme involved in skin barrier function. To guarantee
homeostasis in the stratum corneum the combination and coordi-
nation of several enzymes of lipid synthesis on the one hand and
of lipid metabolism on the other are required (Elias, 1983; 1996;
Grubauer et al, 1989b; Holleran et al, 1993; 1994; 1995; Mao-Qiang
et al, 1996).
There is evidence that in particular a reduction of enzymes in-
volved in ceramide biosynthesis or metabolism may play a role in
frequent skin diseases like atopic eczema and psoriasis. In contrast
to hereditary skin alterations such as in Farbers’ disease or
M. Gaucher, the mechanisms in these diseases are not clear. Several
studies have shown that the fraction of ceramides relative to total
stratum corneum lipids is diminished in patients with atopic ec-
zema in lesional as well as nonlesional skin (Melnik et al, 1988;
Hollmann et al, 1991; Imokawa et al, 1991). These e¡ects have been
related to sphingolipid decomposition (Murata et al, 1996; Cui
et al, 1997), but the role of ceramide biosynthesis is not yet clear.
Preliminary studies of topical therapy for dermatoses triggered by
abnormal barrier function show that application of ceramide-
dominant barrier repair lipids improve atopic dermatitis in chil-
dren (Chamlin et al, 2001). In psoriatic lesional skin alterations in
ceramide composition are associated with increased levels of
TEWL due to a decrease in particular in ceramide 1 (Grice et al,
1973; Motta et al, 1993; Ghadially et al, 1996).We have previously
shown altered levels of prosaposin (a key cofactor for sphingoli-
pid degradation) both in lesional and nonlesional skin of patients
with psoriasis vulgaris (Alessandrini et al, 2001).
Further investigations are necessary to understand the com-
plexity of genetic regulation of skin barrier function and its
physiopathologic relevance.
We wish to thank Prof. Dr. Wilhelm Sto¡el, University of Koeln, Germany, for
providing us with mouse anti-LCB2 antibody for immunostaining.
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